The terms used in the preface to the 2011 INCB annual report leave no doubt as to the illness afflicting this UN body: a (deep) regret  is running through its old veins. Yet again, its poison is directed at Bolivia, that small country which dares to challenge and stretch what is allegedly firm and static, and all in the name of an old indigenous habit. This saga must come to a close sometime soon, both parties must have thought, but as yet no happy ending is in sight.
Suppose the United States government helps to negotiate, and subsequently champions, certain framework treaties – ones justly viewed as imposing significant constraints on all signatories. Down the road, the United States occasionally even calls out counterparties for their looser policy innovations, when the latter push the outer boundaries of what’s permitted under the treaties; a treaty-created monitoring body does likewise in its annual reporting. This pattern essentially holds year in and year out and from one presidential administration to the next.
Producers of prohibited plants face conflict from authorites and the drug market itself. Their communities are stigmatized, criminalized and incarcerated. UN Global drug policy can change this by listening to their demands. Watch our video of the third Global Forum where producers shared experiences and knowledge and ultimately drafted the 'Heemskerk Declaration'
From 7-9 July, 2008, 300 delegates met in Vienna for the Beyond 2008 NGO Forum meant to provide civil society input for the 10-year UNGASS review. The goal was to produce a consensus statement on behalf of the global civil society to the high level governmental meeting of the Commission on Narcotic Drugs (CND), to be held in Vienna in March 2009. The Hungarian Civil Liberty Union (HCLU) produced a 10 minute video interviewing the participants.
Countries that embrace legal regulation find themselves in breach of international law. In this video, we explain a strategy to resolve those treaty tensions and to enable progressive and sustainable change at the global level.
On 28 May 2018, the Transnational Institute and the Epicurus Foundation co-hosted the second edition of the “The Transparent Chain,” a conference on transparent cannabis supply chains in Utrecht, Netherlands.
The voice of communities involved in illicit cultivation had long been excluded from policymaking platforms. However, thanks to growing networks such as the Myanmar Opium Farmers Forum, more and more farmers have gained more space to provide input to drug policy discussions at the UN level.
With an increasing number of jurisdictions enacting or contemplating reforms creating legal access to cannabis for purposes other than exclusively "medical and scientific," tensions regarding the drug conventions and evolving law and practice in Member States continue to grow.
This March, our video advocacy team attended the 58th session of the Commission on Narcotic Drugs, the largest drug policy gathering in the world, to find out how governments and NGOs feel about the prospects of drug policy reform. We produced a series of short thematic videos, to give you an overview of the current state of political debate on the burning issues of international drug control.
Jamie Bridge, Martin Jelsma, Tom Blickman, Marie Nougier, David Bewley-Taylor, Christopher Hallam
29 September 2017
Diplomatic processes at the United Nations are notoriously slow and difficult, perhaps increasingly so in a modern world of multi-polar geopolitics and tensions. This is certainly no different for the highly charged and provocative issue of international drug control.
American attitudes toward marijuana policy are shifting. Recent polls suggest that the majority of Americans think marijuana use should be legalized. How might a shift in American marijuana policies affect the prohibitionist drug treaty system?
As a growing number of countries move towards legal regulation for non-medical cannabis, governments are pushing the boundaries of the three UN drug control treaties. At the 61st session of the Commission on Narcotic Drugs (CND), TNI co-organised a side event to explore the issue, addressing the various challenges and opportunities involved.